Tag Archives: AstraZeneca

NIH-funded TB drug trial is latest effort to fill treatment pipeline

By on .

A 14-day trial enrolling 75 Cape Town South Africa patients, to see if a new investigational drug lowers tuberculosis bacteria counts represents the latest hope for filling the need for treatment options for the disease, the National Institutes of Health announced this week. The NIH is sponsoring the trial led by Case Western Reserve researchers […]